Cargando…

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force

Mostrar otras versiones (1)

OBJECTIVES: Deliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stakeholders. Increasing attention is being given to deliberative processes, but guidance is lacking for those who wish to de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oortwijn, Wija, Husereau, Don, Abelson, Julia, Barasa, Edwine, Bayani, Diana (Dana), Santos, Vania Canuto, Culyer, Anthony, Facey, Karen, Grainger, David, Kieslich, Katharina, Ollendorf, Daniel, Pichon-Riviere, Andrés, Sandman, Lars, Strammiello, Valentina, Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613534/ https://www.ncbi.nlm.nih.gov/pubmed/35667778 http://dx.doi.org/10.1016/j.jval.2022.03.018

Ejemplares similares

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
por: Oortwijn, Wija, et al.
Publicado: (2022)

Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe
por: Oortwijn, Wija, et al.
Publicado: (2019)

Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide
por: Oortwijn, Wija, et al.
Publicado: (2021)

Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework
por: Baltussen, Rob, et al.
Publicado: (2021)

The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan
por: Oortwijn, Wija, et al.
Publicado: (2022)

Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

Use of Evidence-Informed Deliberative Processes – Learning by Doing: Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Culyer, Anthony J.
Publicado: (2019)

ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
por: Langley, Paul C
Publicado: (2019)

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018)

All Male Panels and Other Diversity Considerations for ISPOR
por: Devlin, Nancy J.
Publicado: (2019)

Charging for the use of survey instruments on population health: the case of quality-adjusted life years
por: Teerawattananon, Yot, et al.
Publicado: (2020)

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand
por: Briones, Jamaica, et al.
Publicado: (2022)

Reinforcing Science and Policy, With Suggestions for Future Research: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Culyer, Anthony J.
Publicado: (2022)

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

Ethics in HTA: Examining the "Need for Expansion"
por: Abrishami, Payam, et al.
Publicado: (2017)

All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe
por: Bouvy, Jacoline C., et al.
Publicado: (2019)

Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group – Commentary
por: Wale, Janet L., et al.
Publicado: (2017)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
por: Teerawattananon, Yot, et al.
Publicado: (2021)

Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
por: Bentley, Colene, et al.
Publicado: (2019)

To include or not include: renal dialysis policy in the era of universal health coverage
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
por: Gad, Mohamed, et al.
Publicado: (2020)

Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]()
por: Phelps, Charles E., et al.
Publicado: (2018)

Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5
por: Pitman, Richard, et al.
Publicado: (2012)

Emotion and Deliberative Reasoning in Moral Judgment
por: Cummins, Denise Dellarosa, et al.
Publicado: (2012)

The Place and Importance of Patients in Deliberative Processes
por: Cellier, Marjo S.
Publicado: (2021)

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
por: Butani, Dimple, et al.
Publicado: (2023)

Utilizing deliberative engagement for identifying implementation strategy priorities: lessons learned from an online deliberative forum with dental professionals
por: Gruß, Inga, et al.
Publicado: (2023)

Prioritization of COVID-19 vaccination. The added value of the “VALIDATE” approach
por: Refolo, Pietro, et al.
Publicado: (2022)

El mundo novelesco de Miguel Delibes /
por: Alvar, Manuel, 1923-2001
Publicado: (1987)

Contingency Management and Deliberative Decision-Making Processes
por: Regier, Paul S., et al.
Publicado: (2015)

Age-dependent changes in intuitive and deliberative cooperation
por: Nava, Francesco, et al.
Publicado: (2023)

Priority measures for publicly reporting primary care performance: Results of public engagement through deliberative dialogues in 3 Canadian provinces
por: Slater, Morgan, et al.
Publicado: (2020)

How to Account for Asymmetries in Deliberative Dialogues: Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study"
por: Jiménez-Pernett, Jaime
Publicado: (2023)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study
por: Teerawattananon, Yot, et al.
Publicado: (2005)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand
por: Pattanaphesaj, Juntana, et al.
Publicado: (2010)

Developing the protocol for the evaluation of the health foundation's 'engaging with quality initiative' – an emergent approach
por: Soper, Bryony, et al.
Publicado: (2008)

Using deliberative techniques to engage the community in policy development
por: Gregory, Judy, et al.
Publicado: (2008)

Including the public in pandemic planning: a deliberative approach
por: Braunack-Mayer, Annette J, et al.
Publicado: (2010)

Voting Intention and Choices: Are Voters Always Rational and Deliberative?
por: Lee, I-Ching, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3be3c1mkc9scak56hb5ftmkrqp